Capital Fund Management »

Celldex Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $281k 16k 18.15
2024-12-31 $893k 35k 25.27
2024-09-30 $1.2M 36k 33.99
2024-06-30 $1.6M 44k 37.01